John Kirkpatrick, MD, PhD
Associate Professor of Radiation Oncology and Surgery
Duke University Health System
John Sampson, MD, PhD, MHSC, MBA
Robert H. Wilkins and Gloria Wilkins Professor of Neurosurgery
Chair, Department of Neurosurgery
Duke University Health System
Meghan Coulehan, MPH
Manager, Educational Strategy and Content
Director of Continuing Medical Education
In this engaging discussion-based Webcast, two prominent Duke oncology clinicians—a neurosurgeon and a radiation oncologist—explain the currently available options and clinical guidelines for treating brain metastases. The benefits, limitations, and indications for surgery, stereotactic radiosurgery, and whole-brain radiation therapy are reviewed, as well as patient characteristics that factor into treatment selection.
Upon completion, participants should be able to:
- Understand the benefits, limitations, and indications for use of radiosurgery, neurosurgery, and whole-brain radiation therapy for brain metastases
- Discuss the role of combination and adjuvant therapies in the treatment of metastatic disease
- Explain the individual patient- and disease-related factors that should be considered when planning treatment for brain metastases
This activity is intended primarily for physicians, nurse practitioners, physician assistants, nurses, and pharmacists.
Statement of Need
More than 250,000 cases of brain metastasis are diagnosed annually, and metastasis occurs in 20% to 40% of all cancer patients. The incidence has been increasing in recent years due to improved imaging and the advancement of systemic therapies that prolong survival but lead to metastasis. The management of metastases includes local, global, and combined therapies. Clinicians need comprehensive understanding of the factors favorable for each treatment modality, anticipated clinical outcomes, and effect on quality of life.
Co-provided by Med-IQ® and the Duke University Health System Department of Clinical Education and Professional Development.
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Med-IQ designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Others: Nurse practitioners, physician assistants, and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.
Instructions to Receive Credit
To receive credit, read the introductory CME material, watch the Webcast, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.
Original Release Date: December 19, 2014
Rerelease Date: January 31, 2017
Expiration Date: January 30, 2018
Estimated Time to Complete This Activity: 45 minutes
The evaluation, attestation, and post-test may be accessed by clicking the “Take Post-Test” tab above.
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.
John Kirkpatrick, MD, PhD
Ownership interest (stocks, stock options, or other ownership interest, excluding diversified mutual funds): ClearSight Radiotherapy Products
Contracted research: Varian Medical Systems, Inc.
John Sampson, MD, PhD, MHSC, MBA, has indicated no real or apparent conflicts.
The activity planners and peer reviewers have no financial relationships to disclose.
Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.
For CME-related questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or e-mail firstname.lastname@example.org.
ReachMD requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8/IE9/IE10 are advised to update their browsers for the best experience.
Microsoft Internet Explorer 11.0 or later
Mozilla Firefox - latest version
Google Chrome - latest version
Apple Safari - latest version
Adobe Acrobat Reader® or Adobe Reader
Adobe Flash Player
Adobe Flash Player 9 or later
For technical support, go to https://reachmd.com/pages/about/.
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Med-IQ at 443 543 5200.
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
© 2017 Duke University Health System and Med-IQ®. All rights reserved.